Cointime

Peptineo

company

About

Peptineo provides Nano-based therapeutics for existing and emerging diseases.

  • 11 - 50

Highlights

Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Peptineo represents the new face of biotechnology and bioengineering. The systems-based approach, Peptineo technical solutions involve drug delivery combinations including “tunable” nano-carriers, engineered peptides, re-formulated pharmaceuticals, and as appropriate, recombinant proteins. Additionally, Peptineo is developing technologies that will greatly enhance and accelerate the drug discovery process.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
—
Peptineo has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 5, 2014 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2014 Seed — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Peptineo is funded by 1 investors. ABQid are the most recent investors.
Investor Name Lead Investor Funding Round
ABQid — Seed
Cointime
เนื้อหา
บริษัท